93 related articles for article (PubMed ID: 6981093)
1. Treatment of cell-mediated immunodeficiency with calf thymic hormone (T.P.I.).
Davies EG; Levinsky RJ
Pediatr Res; 1982 Jul; 16(7):573-8. PubMed ID: 6981093
[TBL] [Abstract][Full Text] [Related]
2. Immunologic and clinical investigation on a bovine thymic extract. Therapeutic applications in primary immunoedificiencies.
Aiuti F; Ammirati P; Fiorilli M; D'Amelio R; Franchi F; Calvani M; Businco L
Pediatr Res; 1979 Jul; 13(7):797-802. PubMed ID: 314621
[TBL] [Abstract][Full Text] [Related]
3. Thymosin activity in patients with cellular immunodeficiency.
Wara DW; Goldstein AL; Doyle NE; Ammann AJ
N Engl J Med; 1975 Jan; 292(2):70-4. PubMed ID: 1078552
[TBL] [Abstract][Full Text] [Related]
4. Treatment of combined immunodeficiency with thymic extract (Thymostimulin).
Lin CY; Hsu HC; Chen CL; Shen EY
Ann Allergy; 1987 May; 58(5):379-84. PubMed ID: 3578932
[TBL] [Abstract][Full Text] [Related]
5. Thymic hormone dependent immunodeficiency in an infant with partial trisomy of chromosome 22.
Tovo PA; Davi G; Fraceschini P; Delpiano A
Thymus; 1986; 8(5):313-8. PubMed ID: 3798528
[TBL] [Abstract][Full Text] [Related]
6. Effect of red cell transfusions, thymic hormone and deoxycytidine in severe combined immunodeficiency due to adenosine deaminase deficiency.
Davies EG; Levinsky RJ; Webster DR; Simmonds HA; Perrett D
Clin Exp Immunol; 1982 Nov; 50(2):303-10. PubMed ID: 6983936
[TBL] [Abstract][Full Text] [Related]
7. Clinical consequences and treatment of primary immunodeficiency syndromes characterized by functional T and B lymphocyte anomalies (combined immune deficiency).
Berthet F; Le Deist F; Duliege AM; Griscelli C; Fischer A
Pediatrics; 1994 Feb; 93(2):265-70. PubMed ID: 8121739
[TBL] [Abstract][Full Text] [Related]
8. Therapy with thymopoietin pentapeptide (TP-5) in 26 patients with primary immunodeficiencies.
Aiuti F; Businco L; Fiorilli M; Galli E; Quinti I; Le Moli S; Seminara R; Goldstein G
Birth Defects Orig Artic Ser; 1983; 19(3):267-72. PubMed ID: 6360238
[No Abstract] [Full Text] [Related]
9. In vivo effects of thymic hormones (Imunotim) on immunologic parameters of patients with secondary immunodeficiency diseases.
Crişan M; Stugren C; Gal O; Herold A; Bucurenci N
Roum Arch Microbiol Immunol; 1992; 51(4):213-24. PubMed ID: 1304826
[TBL] [Abstract][Full Text] [Related]
10. Impaired production of interleukins in patients with cell-mediated immunodeficiencies.
Paganelli R; Aiuti F; Beverley PC; Levinsky RJ
Clin Exp Immunol; 1983 Feb; 51(2):338-44. PubMed ID: 6601554
[TBL] [Abstract][Full Text] [Related]
11. Screening for B- and T-cell defects in Egyptian infants and children with suspected primary immunodeficiency.
Hossny E; El-Awady H; El-Feky M; El-Owaidy R
Med Sci Monit; 2009 May; 15(5):CR217-25. PubMed ID: 19396036
[TBL] [Abstract][Full Text] [Related]
12. Improvement of natural killer activity and of T cells after thymopoietin pentapeptide therapy in a patient with severe combined immunodeficiency.
Fiorilli M; Sirianni MC; Pandolfi F; Quinti I; Tosti U; Aiuti F; Goldstein G
Clin Exp Immunol; 1981 Aug; 45(2):344-51. PubMed ID: 7032772
[TBL] [Abstract][Full Text] [Related]
13. Demonstration of abnormalities in expression of thymic epithelial surface antigens in severe cellular immunodeficiency diseases.
Haynes BF; Warren RW; Buckley RH; McClure JE; Goldstein AL; Henderson FW; Hensley LL; Eisenbarth GS
J Immunol; 1983 Mar; 130(3):1182-8. PubMed ID: 6600476
[TBL] [Abstract][Full Text] [Related]
14. A placebo-controlled trial of thymic hormone treatment of recurrent herpes simplex labialis infection in immunodeficient hosts.
Aiuti F; Sirianni MC; Paganelli R; Stella A; Turbessi G; Fiorilli M
Int J Clin Pharmacol Ther Toxicol; 1983 Feb; 21(2):81-6. PubMed ID: 6341261
[TBL] [Abstract][Full Text] [Related]
15. Cell-mediated immunity during natural measles infection.
Whittle HC; Dossetor J; Oduloju A; Bryceson AD; Greenwood BM
J Clin Invest; 1978 Sep; 62(3):678-84. PubMed ID: 308511
[TBL] [Abstract][Full Text] [Related]
16. [Immunocorrective therapy of pyelonephritis in children].
Kirillov VI; Zernov NG; Arion VIa; Tebloeva LT; Riabchikov OP
Urol Nefrol (Mosk); 1989; (5):17-21. PubMed ID: 2595860
[TBL] [Abstract][Full Text] [Related]
17. [Immune defect diseases in childhood].
Zintl F
Z Gesamte Inn Med; 1977 Oct; 32(20):523-8. PubMed ID: 74137
[TBL] [Abstract][Full Text] [Related]
18. NK cell function in severe combined immunodeficiency (SCID): evidence of a common T and NK cell defect in some but not all SCID patients.
Peter HH; Friedrich W; Dopfer R; Müller W; Kortmann C; Pichler WJ; Heinz F; Rieger CH
J Immunol; 1983 Nov; 131(5):2332-9. PubMed ID: 6415162
[TBL] [Abstract][Full Text] [Related]
19. Effect of synthetic thymic hormone (TP5) in children with T-cell immunodeficiencies.
Levinsky RJ; Davies EG; Goldstein G
Birth Defects Orig Artic Ser; 1983; 19(3):273-6. PubMed ID: 6360239
[No Abstract] [Full Text] [Related]
20. Epstein-Barr virus in a malignant lymphoproliferative disorder of B-cells occurring after thymic epithelial transplantation for combined immunodeficiency.
Reece ER; Gartner JG; Seemayer TA; Joncas JH; Pagano JS
Cancer Res; 1981 Nov; 41(11 Pt 1):4243-7. PubMed ID: 6272969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
